Defective Drug News

Celebrex trial stopped after link to increased heart risk is discovered

Posted on November 30, 1999

 

December 17, 2004

 

A trial of Pfizer Inc.’s arthritis drug Celebrex was halted after patients taking the medicine had more than twice as many heart attacks as patients taking a placebo, the company announced.

 

The Celebrex findings were discovered just two-and-a-half months after a rival drug, Vioxx, was recalled from the market when a study found the drug doubled the incidence of heart attack and stroke among patients taking it for more than 18 months.

 

Both Celebrex and Vioxx belong to a class of drugs called COX-2 inhibitors. After Vioxx was recalled, the safety of the entire class of drugs has been questioned, but the belief was that Celebrex was somehow safer than other COX-2s.

 

Pfizer has not indicated if the company is considering pulling Celebrex from the market.

 

For more information on Celebrex warnings, please contact us to confer with a Celebrex Lawyer and learn your legal rights and options.

 

 

 

More Recent Defective Drug News

 

This entry was posted in Celebrex. Bookmark the permalink.
Free Consultation Use this form to request a free consultation with a qualified attorney near you.

*

Note: The use of the Internet for communications with the firm will not establish an attorney-client relationship and messages containing confidential or time-sensitive information should not be sent. I agree that submitting this form does not create an attorney-client relationship and that the information I am providing may be used to check for conflicts of interest to determine if the firm can assist me with my legal inquiry. I Agree:*

ATTORNEY ADVERTISING
Flood Law Group, LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private
FREE